14 Stocks That Jim Cramer Recently Talked About

9. Illumina, Inc. (NASDAQ:ILMN)

Number of Hedge Fund Holders In Q3 2024: 54

Illumina, Inc. (NASDAQ:ILMN) is a specialty medical raw materials provider that caters to the needs of the gene testing industry. As its target market is susceptible to high rates, the shares have gained a modest 8% year-to-date, and these gains have come on the back of a 10.5% rise since mid-November. The rise occurred after UK regulators approved Vertex’s gene therapy for Sickle Cell disease which signaled to investors that the market for Illumina, Inc. (NASDAQ:ILMN)’s products could grow in the future. After jumping by 2.3% after trading opened, the firm’s shares lost most of these gains. Cramer commented on the firm’s removal from the NASDAQ 100 index:

“Illumina you could argue it’s China.”